First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
- Kim, T.W.
- Burris, H.A.
- de Miguel Luken, M.J.
- Pishvaian, M.J.
- Bang, Y.-J.
- Gordon, M.
- Awada, A.
- Camidge, D.R.
- Hodi, F.S.
- McArthur, G.A.
- Miller, W.H.
- Cervantes, A.
- Chow, L.Q.
- Lesokhin, A.M.
- Rutten, A.
- Sznol, M.
- Rishipathak, D.
- Chen, S.-C.
- Stefanich, E.
- Pourmohamad, T.
- Anderson, M.
- Kim, J.
- Huseni, M.
- Rhee, I.
- Siu, L.L.
ISSN: 1557-3265, 1078-0432
Argitalpen urtea: 2022
Alea: 28
Zenbakia: 16
Orrialdeak: 3452-3463
Mota: Artikulua